Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain
- 7 September 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 349 (4) , 1301-1307
- https://doi.org/10.1016/j.bbrc.2006.08.171
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Overexpression of podoplanin in oral cancer and its association with poor clinical outcomeCancer, 2006
- Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profilingNature Methods, 2005
- Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell TumorsThe American Journal of Pathology, 2005
- Podoplanin as a marker for mesotheliomaPathology International, 2005
- Enhanced Expression of Aggrus (T1alpha/Podoplanin), a Platelet-Aggregation-Inducing Factor in Lung Squamous Cell CarcinomaTumor Biology, 2005
- Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumorsOncogene, 2004
- Functional Sialylated O-Glycan to Platelet Aggregation on Aggrus (T1α/Podoplanin) Molecules Expressed in Chinese Hamster Ovary CellsPublished by Elsevier ,2004
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999
- Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.Journal of Clinical Investigation, 1991
- The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregationBiochemical and Biophysical Research Communications, 1987